F. Hoffmann-La Roche Ltd.

In News

Transforming autoimmune treatment: How data-driven therapies are changing patient outcomes - roche.com

roche.com - Jul 06, 2026

F. Hoffmann-La Roche Ltd - Via Ritzau

Via Ritzau - Sep 17, 2026

Roche’s Lunsumio-based regimen significantly improves progression-free survival in follicular lymphoma in phase III CELESTIMO study - Yahoo Finance UK

Yahoo Finance UK - Sep 17, 2026

F. Hoffmann-La Roche Ltd - Via Ritzau

Via Ritzau - Sep 18, 2026

Roche nabs Simcere’s preclinical trispecific TCE in $1.53B deal - BioWorld News

BioWorld News - Sep 08, 2026

Roche signs $2.3bn blood cancer drug agreement with Nurix Therapeutics - Pharmaceutical Technology

Pharmaceutical Technology - Jun 08, 2026

Roche’s collaborator MediLink announces phase III data for Tam-Peli showing significantly improved overall survival in Chinese patient population with relapsed small-cell lung cancer - Yahoo Finance UK

Yahoo Finance UK - Sep 13, 2026

Roche presents new data in Alzheimer’s disease from across its integrated pharmaceutical and diagnostics portfolio at AAIC - Yahoo Finance

Yahoo Finance - Jul 07, 2026

F. Hoffmann-La Roche Ltd - Via Ritzau

Via Ritzau - Sep 10, 2026

Roche announces global collaboration with Nurix Therapeutics to co-develop and co-commercialise potential best-in-class BTK degrader bexobrutideg across malignant haematology, immunology and neurology - Yahoo Finance

Yahoo Finance - Jun 07, 2026

F. Hoffmann-La Roche Ltd - Via Ritzau

Via Ritzau - Aug 20, 2026

Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics - Yahoo Finance UK

Yahoo Finance UK - May 07, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment